Literature DB >> 9840707

Cat eye syndrome with hypogonadotropic hypogonadism.

H Masukawa1, T Ozaki, T Nogimori.   

Abstract

A 17-year-old male diagnosed as having Cat Eye Syndrome (CES) with hypogonadotropic hypogonadism showed short stature and no development of secondary sex characteristics. Exogeneous gonadotropin replacement therapy combining human chorionic gonadotropin (hCG) and human menopausal gonadotropin (hMG) was started. As a result, the short stature and androgen deficiency were relieved. The critical region of CES was tetrasomy of 22 pter-->q11. Abnormalities of other chromosomes which cause hypogonadotropic hypogonadism may exist, thus further investigation is needed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9840707     DOI: 10.2169/internalmedicine.37.853

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  3 in total

1.  Congenital idiopathic hypogonadotropic hypogonadism: evidence of defects in the hypothalamus, pituitary, and testes.

Authors:  Gerasimos P Sykiotis; Xuan-Huong Hoang; Magdalena Avbelj; Frances J Hayes; Apisadaporn Thambundit; Andrew Dwyer; Margaret Au; Lacey Plummer; William F Crowley; Nelly Pitteloud
Journal:  J Clin Endocrinol Metab       Date:  2010-04-09       Impact factor: 5.958

2.  A 600 kb triplication in the cat eye syndrome critical region causes anorectal, renal and preauricular anomalies in a three-generation family.

Authors:  Jeroen Knijnenburg; Yolande van Bever; Lorette O M Hulsman; Chantal A P van Kempen; Galhana M Bolman; Rosa Laura E van Loon; H Berna Beverloo; Laura J C M van Zutven
Journal:  Eur J Hum Genet       Date:  2012-03-07       Impact factor: 4.246

3.  Congenital hypopituitarism and multiple midline defects in a newborn with non-familial Cat Eye syndrome.

Authors:  Gregorio Serra; Clara Giambrone; Vincenzo Antona; Francesca Cardella; Maurizio Carta; Marcello Cimador; Giovanni Corsello; Mario Giuffrè; Vincenzo Insinga; Maria Cristina Maggio; Marco Pensabene; Ingrid Anne Mandy Schierz; Ettore Piro
Journal:  Ital J Pediatr       Date:  2022-09-08       Impact factor: 3.288

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.